Emergent Biosolutions (EBS) Profit Margin (2010 - 2026)
Emergent Biosolutions (EBS) profit margin from Jun 30, 2010 to Mar 31, 2026. The current Emergent Biosolutions (EBS) profit margin is 4.36%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Emergent Biosolutions (EBS)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 7.08% | -138.77% |
| 2024 | -18.26% | -74.80% |
| 2023 | -72.48% | +282.76% |
| 2022 | -18.94% | -6.68% |
| 2022 | -20.29% | -263.95% |
| 2021 | 12.38% | -53.03% |
| 2021 | 26.35% | -286.71% |
| 2021 | -14.11% | -179.05% |
| 2021 | 17.85% | +49.76% |
| 2020 | 11.92% | -38.52% |
| 2020 | 19.39% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | 4.93% | -64.43% |
| 2019 | 13.86% | -454.69% |
| 2019 | -3.91% | -71.47% |
| 2019 | -13.69% | -270.88% |
| 2018 | 8.01% | -33.40% |
| 2018 | 12.03% | -47.12% |
| 2018 | 22.75% | -646.98% |
| 2018 | -4.16% | -128.25% |
| 2017 | 14.73% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2016 | 10.60% | -29.03% |
| 2016 | 14.93% | -224.42% |
| 2016 | -12.00% | -409.69% |
| 2016 | 3.88% | -69.84% |
| 2015 | 12.85% | -44.91% |
| 2015 | 23.32% | +96.88% |
| 2015 | 11.85% | -128.71% |
| 2015 | -41.27% | -554.29% |
| 2014 | 9.08% | -42.60% |
| 2014 | 15.82% | +247.10% |
| 2014 | 4.56% | -112.14% |
| 2014 | -37.56% | -477.28% |
| 2013 | 9.96% | -34.24% |
| 2013 | 15.14% | +19.10% |
| 2013 | 12.71% | -167.98% |
| 2013 | -18.70% | -324.13% |
| 2012 | 8.34% | -16.07% |
| 2012 | 9.94% | -8.30% |
| 2012 | 10.84% | -179.86% |
| 2012 | -13.58% | -261.22% |
| 2011 | 8.42% | +219.22% |
| 2011 | 2.64% | -83.64% |
| 2011 | 16.12% | -113.96% |
| 2011 | -115.49% | -739.25% |
| 2010 | 18.07% | +36.22% |
| 2009 | 13.26% | N/A |
Comparison Emergent Biosolutions (EBS) profit margin with competitors
Emergent Biosolutions (EBS) profit margin is 4.36%.